The breast and ovary cancer cases were similar for both genes with 7 and 6 cases for BRCA1 and BRCA2, respectively, while the 3 cases of male breast cancer (one bilateral) presented a mutation only in BRCA2 (Supplementary table). This evidence concerns the gene BRCA2 and male breast carcinoma.